Logo image of CPR.MI

DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis

BIT:CPR - Euronext Milan - NL0015435975 - Common Stock - Currency: EUR

6.198  -0.18 (-2.76%)

Fundamental Rating

4

CPR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 25 industry peers in the Beverages industry. CPR has an average financial health and profitability rating. CPR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

CPR had positive earnings in the past year.
In the past year CPR had a positive cash flow from operations.
In the past 5 years CPR has always been profitable.
Each year in the past 5 years CPR had a positive operating cash flow.
CPR.MI Yearly Net Income VS EBIT VS OCF VS FCFCPR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

1.2 Ratios

CPR has a Return On Assets of 4.00%. This is in the better half of the industry: CPR outperforms 61.54% of its industry peers.
CPR has a Return On Equity of 8.77%. This is in the better half of the industry: CPR outperforms 61.54% of its industry peers.
CPR has a Return On Invested Capital of 6.05%. This is in the lower half of the industry: CPR underperforms 69.23% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CPR is in line with the industry average of 7.88%.
Industry RankSector Rank
ROA 4%
ROE 8.77%
ROIC 6.05%
ROA(3y)5.36%
ROA(5y)5.32%
ROE(3y)11.92%
ROE(5y)11.62%
ROIC(3y)7.65%
ROIC(5y)7.25%
CPR.MI Yearly ROA, ROE, ROICCPR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

With a decent Profit Margin value of 11.17%, CPR is doing good in the industry, outperforming 76.92% of the companies in the same industry.
In the last couple of years the Profit Margin of CPR has declined.
The Operating Margin of CPR (20.66%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CPR has remained more or less at the same level.
With a decent Gross Margin value of 57.81%, CPR is doing good in the industry, outperforming 73.08% of the companies in the same industry.
In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
Industry RankSector Rank
OM 20.66%
PM (TTM) 11.17%
GM 57.81%
OM growth 3Y7.15%
OM growth 5Y-1.01%
PM growth 3Y2.21%
PM growth 5Y-8.14%
GM growth 3Y0.2%
GM growth 5Y-0.61%
CPR.MI Yearly Profit, Operating, Gross MarginsCPR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CPR is still creating some value.
Compared to 1 year ago, CPR has more shares outstanding
CPR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CPR has a worse debt to assets ratio.
CPR.MI Yearly Shares OutstandingCPR.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CPR.MI Yearly Total Debt VS Total AssetsCPR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

CPR has an Altman-Z score of 2.52. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
CPR has a better Altman-Z score (2.52) than 65.38% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that CPR is somewhat dependend on debt financing.
CPR has a Debt to Equity ratio of 0.66. This is in the better half of the industry: CPR outperforms 73.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Altman-Z 2.52
ROIC/WACC0.86
WACC7.03%
CPR.MI Yearly LT Debt VS Equity VS FCFCPR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B

2.3 Liquidity

A Current Ratio of 2.61 indicates that CPR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.61, CPR belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
A Quick Ratio of 1.06 indicates that CPR should not have too much problems paying its short term obligations.
The Quick ratio of CPR (1.06) is better than 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 2.61
Quick Ratio 1.06
CPR.MI Yearly Current Assets VS Current LiabilitesCPR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CPR have decreased strongly by -39.19% in the last year.
CPR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.93% yearly.
CPR shows a small growth in Revenue. In the last year, the Revenue has grown by 2.96%.
Measured over the past years, CPR shows a quite strong growth in Revenue. The Revenue has been growing by 11.26% on average per year.
EPS 1Y (TTM)-39.19%
EPS 3Y21.31%
EPS 5Y2.93%
EPS Q2Q%-53.37%
Revenue 1Y (TTM)2.96%
Revenue growth 3Y18.1%
Revenue growth 5Y11.26%
Sales Q2Q%4.5%

3.2 Future

CPR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.95% yearly.
CPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.48% yearly.
EPS Next Y-13.43%
EPS Next 2Y-3.51%
EPS Next 3Y2.01%
EPS Next 5Y6.95%
Revenue Next Year3.21%
Revenue Next 2Y4.66%
Revenue Next 3Y5.13%
Revenue Next 5Y5.48%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CPR.MI Yearly Revenue VS EstimatesCPR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
CPR.MI Yearly EPS VS EstimatesCPR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.2 0.4 0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 32.62, which means the current valuation is very expensive for CPR.
Based on the Price/Earnings ratio, CPR is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
CPR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.35.
CPR is valuated rather expensively with a Price/Forward Earnings ratio of 19.41.
CPR's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CPR is more expensive than 73.08% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. CPR is around the same levels.
Industry RankSector Rank
PE 32.62
Fwd PE 19.41
CPR.MI Price Earnings VS Forward Price EarningsCPR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 61.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.37
CPR.MI Per share dataCPR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)11.14
EPS Next 2Y-3.51%
EPS Next 3Y2.01%

More info and screens

2

5. Dividend

5.1 Amount

CPR has a Yearly Dividend Yield of 1.02%.
CPR's Dividend Yield is slightly below the industry average, which is at 2.64.
With a Dividend Yield of 1.02, CPR pays less dividend than the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 1.02%

5.2 History

The dividend of CPR decreases each year by -4.99%.
Dividend Growth(5Y)-4.99%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

23.43% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP23.43%
EPS Next 2Y-3.51%
EPS Next 3Y2.01%
CPR.MI Yearly Income VS Free CF VS DividendCPR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M
CPR.MI Dividend Payout.CPR.MI Dividend Payout, showing the Payout Ratio.CPR.MI Dividend Payout.PayoutRetained Earnings

More info and screens

DAVIDE CAMPARI-MILANO NV

BIT:CPR (3/7/2025, 7:00:00 PM)

6.198

-0.18 (-2.76%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)03-04 2025-03-04/amc
Earnings (Next)05-08 2025-05-08
Inst Owners23.33%
Inst Owner ChangeN/A
Ins Owners52.32%
Ins Owner ChangeN/A
Market Cap7.63B
Analysts71.11
Price Target7.91 (27.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.02%
Yearly Dividend0.04
Dividend Growth(5Y)-4.99%
DP23.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.7%
PT rev (3m)-5.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.91%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.58%
Valuation
Industry RankSector Rank
PE 32.62
Fwd PE 19.41
P/S 2.56
P/FCF N/A
P/OCF 18.41
P/B 2.01
P/tB N/A
EV/EBITDA 13.37
EPS(TTM)0.19
EY3.07%
EPS(NY)0.32
Fwd EY5.15%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.34
OCFY5.43%
SpS2.42
BVpS3.09
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)11.14
Profitability
Industry RankSector Rank
ROA 4%
ROE 8.77%
ROCE 8.58%
ROIC 6.05%
ROICexc 6.56%
ROICexgc 15.85%
OM 20.66%
PM (TTM) 11.17%
GM 57.81%
FCFM N/A
ROA(3y)5.36%
ROA(5y)5.32%
ROE(3y)11.92%
ROE(5y)11.62%
ROIC(3y)7.65%
ROIC(5y)7.25%
ROICexc(3y)8.83%
ROICexc(5y)8.52%
ROICexgc(3y)27.99%
ROICexgc(5y)32.96%
ROCE(3y)10.84%
ROCE(5y)10.28%
ROICexcg growth 3Y1.19%
ROICexcg growth 5Y-3.69%
ROICexc growth 3Y11.02%
ROICexc growth 5Y1.99%
OM growth 3Y7.15%
OM growth 5Y-1.01%
PM growth 3Y2.21%
PM growth 5Y-8.14%
GM growth 3Y0.2%
GM growth 5Y-0.61%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Debt/EBITDA 3.44
Cap/Depr 380.97%
Cap/Sales 15.03%
Interest Coverage 7.15
Cash Conversion 56.46%
Profit Quality N/A
Current Ratio 2.61
Quick Ratio 1.06
Altman-Z 2.52
F-Score4
WACC7.03%
ROIC/WACC0.86
Cap/Depr(3y)287.22%
Cap/Depr(5y)219.67%
Cap/Sales(3y)10.23%
Cap/Sales(5y)8.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.19%
EPS 3Y21.31%
EPS 5Y2.93%
EPS Q2Q%-53.37%
EPS Next Y-13.43%
EPS Next 2Y-3.51%
EPS Next 3Y2.01%
EPS Next 5Y6.95%
Revenue 1Y (TTM)2.96%
Revenue growth 3Y18.1%
Revenue growth 5Y11.26%
Sales Q2Q%4.5%
Revenue Next Year3.21%
Revenue Next 2Y4.66%
Revenue Next 3Y5.13%
Revenue Next 5Y5.48%
EBIT growth 1Y1.15%
EBIT growth 3Y26.54%
EBIT growth 5Y10.13%
EBIT Next Year20.73%
EBIT Next 3Y13.92%
EBIT Next 5Y10.83%
FCF growth 1Y-112.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.66%
OCF growth 3Y-16.84%
OCF growth 5Y-13.83%